Susan Julien

Susan Julien has a diverse and extensive work experience in the biotechnology industry. Susan most recently worked at Mozart Therapeutics, Inc as an Associate Director, starting in October 2021. Prior to that, they held the position of Principal Scientist at the same company from October 2020 to October 2021.

Before joining Mozart Therapeutics, Susan worked at AGC Biologics as a Senior Scientist from April 2019 to September 2020. In this role, they led the R&D Center Cell Line Development and was responsible for optimizing the stable CHO CHEF1 expression system. Susan also played a key role in establishing a high-throughput CLD process and collaborating with external partners.

Susan spent a significant portion of their career at Bristol-Myers Squibb, starting in 2008. Susan held various roles at the company, including Senior Scientist II, Senior Scientist I, and Scientist. As a Process Development Lead, they initiated and optimized a manufacturing process of a critical enzyme for Antibody and Immunomodulatory Drug Conjugates. Susan also led protein engineering efforts and was accountable for R&D reagent generation and therapeutic candidate design. Additionally, they worked as a Scientist, focusing on antibody-like alternative scaffolds and bispecific antibody therapeutics expressed in E. coli.

Susan began their career at ZymoGenetics in 1993 and continued working there until it was acquired by Bristol-Myers Squibb in 2010. Susan started as a Research Associate and progressed to become an Associate Scientist. Susan'swork involved microbial production and protein engineering, with a focus on optimizing expression in various cell lines.

Overall, Susan Julien has a strong background in protein engineering, process development, and cell line optimization, with experience in both industry and academic settings.

Susan Julien attended the University of Washington, where they pursued a Bachelor of Science degree in Cell and Molecular Biology. During their time at the university, they studied molecular biology, genetics, and art history. No specific information regarding the start and end years of their education is provided.